Ubs Group Ag Enzo Biochem Inc Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Enzo Biochem Inc stock. As of the latest transaction made, Ubs Group Ag holds 45,713 shares of ENZ stock, worth $25,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,713

Previous 278 16343.53%

Holding current value

$25,142

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.37 - $0.74 $16,810 - $33,621	45,435 Added 16343.53%	45,713 $16,000
Q3 2024 Nov 14, 2024	SELL	$1.04 - $1.18 $462 - $525	-445 Reduced 61.55%	278 $0
Q2 2024 Aug 13, 2024	BUY	$1.04 - $1.28 $462 - $569	445 Added 160.07%	723 $0
Q1 2024 May 13, 2024	SELL	$1.21 - $1.5 $1,931 - $2,394	-1,596 Reduced 85.17%	278 $0
Q4 2023 Feb 09, 2024	BUY	$1.21 - $1.44 $2,267 - $2,698	1,874 New	1,874 $2,000
Q2 2023 Aug 11, 2023	BUY	$1.84 - $2.66 $1,138 - $1,646	619 New	619 $1,000
Q4 2022 Feb 08, 2023	BUY	$1.16 - $2.42 $1,569 - $3,274	1,353 New	1,353 $1,000
Q1 2022 May 16, 2022	SELL	$2.9 - $3.47 $8,059 - $9,643	-2,779 Reduced 86.74%	425 $1,000
Q4 2021 Feb 14, 2022	SELL	$3.17 - $4.09 $3,677 - $4,744	-1,160 Reduced 26.58%	3,204 $10,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $3.77 $9,442 - $11,826	3,137 Added 255.66%	4,364 $16,000
Q2 2021 Aug 13, 2021	SELL	$2.86 - $3.61 $22,039 - $27,818	-7,706 Reduced 86.26%	1,227 $4,000
Q1 2021 May 12, 2021	SELL	$2.61 - $4.08 $10,635 - $16,626	-4,075 Reduced 31.33%	8,933 $30,000
Q4 2020 Feb 11, 2021	BUY	$1.82 - $2.61 $12,144 - $17,416	6,673 Added 105.34%	13,008 $33,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $17,493 - $26,153	-8,660 Reduced 57.75%	6,335 $13,000
Q2 2020 Jul 31, 2020	SELL	$2.12 - $3.22 $28,952 - $43,975	-13,657 Reduced 47.67%	14,995 $34,000
Q1 2020 May 01, 2020	SELL	$1.82 - $3.87 $53,830 - $114,462	-29,577 Reduced 50.79%	28,652 $72,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $3.68 $23,877 - $34,190	9,291 Added 18.99%	58,229 $153,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $4.0 $84,701 - $112,560	28,140 Added 135.3%	48,938 $176,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $17,878 - $27,618	6,408 Added 44.53%	20,798 $70,000
Q1 2019 May 14, 2019	SELL	$2.54 - $4.02 $48,239 - $76,347	-18,992 Reduced 56.89%	14,390 $39,000
Q4 2018 Feb 14, 2019	BUY	$2.46 - $4.2 $20,587 - $35,149	8,369 Added 33.46%	33,382 $93,000
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $7,673 - $11,137	2,014 Added 8.76%	25,013 $103,000
Q2 2018 Aug 14, 2018	BUY	$5.06 - $6.78 $36,953 - $49,514	7,303 Added 46.53%	22,999 $119,000
Q1 2018 May 15, 2018	SELL	$5.43 - $8.36 $29,446 - $45,336	-5,423 Reduced 25.68%	15,696 $86,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $219,887 - $284,639	-26,980 Reduced 56.09%	21,119 $172,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $13,814 - $15,123	1,322 Added 2.83%	48,099 $504,000
Q2 2017 Aug 14, 2017	SELL	N/A	-538 Reduced 1.14%	46,777 $516,000
Q1 2017 Nov 14, 2017	BUY	N/A	47,315	47,315 $396,000

Others Institutions Holding ENZ

# of Institutions

Shares Held

16.3M

Call Options Held

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $26.8M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account